Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Study: Drug used to treat blood loss may be beneficial for some stroke patients

Patients with stroke caused by bleeding on the brain may benefit from receiving a drug currently used to treat blood loss from major trauma and bleeding after childbirth, an international trial has revealed.

16 May 2018

Study: Alcohol use prolongs hospital length of stay after lung transplant

Lung transplant patients who showed evidence of alcohol use before their transplants spent more time in the hospital and on the ventilator, according to a study by Loyola University Chicago and Loyola Medicine researchers.

16 May 2018

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.

16 May 2018

BU postdoctoral researcher wins competitive NIH Pathway to Independence Award

Duo Zhang, PhD, a postdoctoral associate at Boston University School of Medicine, has received the highly competitive National Institutes of Health Pathway to Independence Award.

15 May 2018

Drug-resistant staph infections found to be deadly, but less costly

Staph infections, whether MRSA (resistant to methicillin) or susceptible, are important and deadly. Drug-resistant staph infections continue to be deadlier than those that are not resistant and treatable with traditional antibiotics, but treatment costs surprisingly are the same or slightly less, a new national analysis shows.

15 May 2018

Mindfulness-based stress reduction may motivate people to move, shows study

A meditation and stress reduction program may be as effective at getting people to move more as structured exercise programs, according to a new study led by an Iowa State University researcher.

15 May 2018

Researchers lab-test molecule that may combat common cold virus

Researchers have lab-tested a molecule that can combat the common cold virus by preventing it from hijacking human cells.

15 May 2018

Study: Effective intervention can reduce medication overuse in aged care facilities

Effective intervention can reduce medication overuse in Residential Aged Care Facilities, the latest University of Tasmania research shows.

14 May 2018

FDA approves new drug to treat MS in pediatric patients

The U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age 10 years and older. This is the first FDA approval of a drug to treat MS in pediatric patients.

14 May 2018

Study explains anti-obesity effects of melatonin

A new study has revealed the mechanism behind the anti-obesity effects of melatonin, a hormone that is released by the pineal gland in the brain overnight.

11 May 2018

Addressing Antimicrobial Resistance Through Industry

Antimicrobial resistance is currently one of the biggest health threats in the world. Gary Cohen and Steve Conly discuss the role of Becton, Dickinson & Co and other organizations in the private sector in combating the spread of resistance.

11 May 2018

New study shows MRSA is no more expensive to treat than MSSA

A new study from the Center for Disease Dynamics, Economics & Policy, with collaborators from Johns Hopkins University and University of Texas Southwestern Medical Center, found that infections caused by one of the most common drug resistant bacteria in the US--methicillin-resistant Staphylococcus aureus, known as MRSA--are no more expensive to treat than MSSA, the methicillin-susceptible version of the same bacteria.

10 May 2018

Flushing the bladder with common chemotherapy drug after surgery can reduce bladder cancer recurrence

Flushing the bladder with a common chemotherapy drug immediately after surgery significantly reduces the chances of bladder cancer returning, according to a major study by SWOG, an international clinical trials network funded by the National Cancer Institute.

9 May 2018

FDA grants approval for two drugs administered together to treat aggressive form of thyroid cancer

The U.S. Food and Drug Administration approved Tafinlar (dabrafenib) and Mekinist (trametinib), administered together, for the treatment of anaplastic thyroid cancer (ATC) that cannot be removed by surgery or has spread to other parts of the body (metastatic), and has a type of abnormal gene, BRAF V600E (BRAF V600E mutation-positive).

8 May 2018

Beaumont and GVSU team up to develop lifesaving cough-assist device

The act of coughing may seem annoying, but for those who can no longer cough on their own because of a medical condition, it's a matter of life and death. Today, more people are surviving brain/spinal cord injuries caused by stroke and automobile accidents.

7 May 2018

Researchers discover how key brain receptor can function in hostile environment

During a stroke or an epileptic seizure, neurons in affected parts of the brain fire at an abnormally rapid rate.

7 May 2018

Phase 2 clinical study of universal influenza vaccine begins in the United States

A Phase 2 clinical trial of an investigational universal influenza vaccine intended to protect against multiple strains of the virus has begun in the United States.

4 May 2018

Study shows how bacterial toxins can cripple normal cellular activity

Bacterial toxins can wreak mass havoc within cells by shutting down multiple essential functions at once, a new study has found.

4 May 2018

UTHealth experts reveal how everyone can make a difference in infection control

When it comes to the examination room at your health care clinic, you might think that avoiding catching the flu or other more deadly viruses is out of your hands, so to speak.

4 May 2018

COPD-related inflammation prevented in experimental model

Chronic obstructive pulmonary disease, or COPD for short, is believed to be the third most common cause of death worldwide. However, because the underlying mechanism is still largely unknown, today's treatments can only slow progression of the disease.

3 May 2018